Pure Global

Domperidone Expanded Access Treatment Program - Trial NCT04996134

Access comprehensive clinical trial information for NCT04996134 through Pure Global AI's free database. This phase not specified trial is sponsored by Aurora Health Care and is currently Available. The study focuses on Gastroparesis.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT04996134
Available
drug
Trial Details
ClinicalTrials.gov โ€ข NCT04996134
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Domperidone Expanded Access Treatment Program
Domperidone Protocol - FDA Expanded Access Program

Study Focus

Gastroparesis

Domperidone Oral Product

Expanded access

drug

Sponsor & Location

Aurora Health Care

Green Bay, United States of America

Timeline & Enrollment

N/A

N/A

N/A

Summary

To allow the use of domperidone by patients with gastrointestinal disorders who have failed
 standard therapy.

ICD-10 Classifications

Attention to gastrostomy
Gastrostomy status
Other gastritis
Gastritis, unspecified
Gastric diverticulum

Data Source

ClinicalTrials.gov

NCT04996134

Non-Device Trial